09:46 AM EST - Miraculins Inc. : announced that the Company has finalized the major terms of a definitive agreement, that would see the Scout DS® Diabetes Screening Test distributed exclusively in China by Cachet Pharmaceutical Co., Ltd. These terms are substantially similar to those outlined in the Company's term sheet announcement made January 31, 2014, and include the placement of an initial order for Scout DS® devices valued at $15 Million U.S. on the signing of the Agreement, to be activated upon Chinese Food and Drug Administration regulatory clearance. Miraculins Inc.
shares V.MOM are trading up $0.005 at $0.15.
